Why Apellis Pharmaceuticals Stock Was Tumbling on Tuesday
Tuesday's big news with Apellis Pharmaceuticals (NASDAQ: APLS) wasn't all that favorable to the company. It released its third-quarter results, and the market …
Read MoreTuesday's big news with Apellis Pharmaceuticals (NASDAQ: APLS) wasn't all that favorable to the company. It released its third-quarter results, and the market …
Read MoreShares of video game company Nintendo (OTC: NTDOY) dropped on Tuesday after the company reported financial results. The Japanese company reports infrequently …
Read MoreCoinbase (NASDAQ: COIN) stock has pulled back recently as the company's growth from trading and stablecoins has slowed. But the opportunity may be bigger than …
Read MoreThere are millions of millionaires in America. According to the 2024 Global Wealth Report from UBS, “In 2023, the U.S. was home to the highest number of …
Read MoreAs a pandemic-era star fallen from grace in recent times, Teladoc Health (NYSE: TDOC) nevertheless remains prominent in the telehealth space — in fact, …
Read MoreWhen it comes to explaining the growth in tech stocks over the last two years, most investors will credit artificial intelligence (AI). To this end, stocks …
Read MoreWhile the debate over whether it's better to pay for high-quality or high-growth businesses will never end, the easiest solution is to find stocks offering …
Read MoreIn this video, Motley Fool contributor Jason Hall digs deep into the latest results from Lemonade (NYSE: LMND), including the biggest thing the company needed …
Read MoreFirst Solar (NASDAQ: FSLR) is one of the most valuable companies in the solar industry, but U.S. subsidies drive its profits. Is that sustainable? Travis Hoium …
Read MoreWell, we finally made it. After a switch in who the Democratic party planned to nominate, numerous controversies, and close to $16 billion in estimated …
Read More